News
Eli Lilly hikes Mounjaro prices in the UK
Digest more
Zacks.com on MSN9m
Lilly Stock Down 5% This Month: Should You Buy the Dip?
Eli Lilly stock is down 5% this month despite strong Q2 results and raised guidance, as data from a study on the obesity pill ...
Eli Lilly looks attractively valued, with P/E ratios well below historical averages and robust momentum in Zepbound and ...
Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to ...
Ozempic sales have risen five-fold after a 126 per cent rise in the price of the Mounjaro drug due to pressure from US ...
Lilly has presented results from a phase 3 trial in which Mounjaro measures up head-to-head against the company’s GLP-1 Trulicity in reducing cardiovascular risks in patients with Type 2 ...
Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...
Mounjaro manufacturer Eli Lilly said it was raising the price by up to 170% which could hit people paying privately for the ...
Straight Arrow News on MSN4d
Eli Lilly accused of bribing doctors to prescribe Mounjaro and other drugs
Texas Attorney General Ken Paxton filed a lawsuit against Eli Lilly, accusing the drug maker of bribing doctors to prescribe ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback